Glutamate

Glutamate (also called glutamic acid) is an amino acid that serves as the brain's principal excitatory neurotransmitter, present at the majority of synapses in the central nervous system. Unlike many neurotransmitters synthesised through dedicated pathways, it is drawn from the general amino acid pool — the same molecule used in protein construction and energy metabolism.

Its abundance makes it a hub molecule. Virtually every circuit in the brain depends on glutamate for fast excitatory signalling, and it is especially central to learning, memory, and neuroplasticity — the ability of connections between neurons to strengthen or weaken over time.

How it works · its role

Glutamate acts on two broad receptor families. Ionotropic receptors — NMDA, AMPA, and kainate subtypes — are ion channels that open directly when glutamate binds, allowing charged particles to rush into the neuron and trigger firing. Metabotropic receptors (mGluRs) couple to slower intracellular signalling cascades and tend to modulate rather than directly drive activity.

The NMDA receptor is especially important for learning. It functions as a coincidence detector, opening fully only when the receiving neuron is already active — making it central to long-term potentiation (LTP), the synaptic strengthening thought to underlie memory formation.

After release, glutamate is cleared from the synapse rapidly by transporters on both neurons and surrounding glial cells. Glial cells convert it to glutamine and shuttle it back to neurons to replenish the transmitter pool.

Relevance to substances & effects

Dissociative anaesthetics — ketamine, phencyclidine (PCP), and related compounds — act primarily by blocking the NMDA receptor's ion channel. This produces the characteristic dissociative state: detachment from the body, perceptual distortion, and at higher doses, the profound disconnection sometimes called a k-hole. Dextromethorphan (DXM), at high doses, works by the same mechanism.

Alcohol also inhibits NMDA receptors, which contributes to its sedating and amnesic effects alongside its action on other receptor systems.

Classic psychedelics and empathogens interact with glutamate more indirectly — serotonin receptor activation produces downstream shifts in glutamate release within prefrontal circuits, and this glutamatergic component is thought to contribute to the cognitive and perceptual effects they produce.

Tolerance & dependence

Chronic alcohol use causes the brain to compensate for persistent NMDA inhibition by upregulating NMDA receptors — increasing their number and sensitivity. When alcohol is removed, this rebound effect glutamate hyperactivity is a primary driver of withdrawal symptoms: tremor, anxiety, and in severe cases, seizures.

A similar compensatory upregulation occurs with regular use of other NMDA antagonists such as ketamine, contributing to tolerance and the gradual dose escalation that can accompany heavy, repeated use.

Clinical · risk note

When glutamate signalling becomes excessive — through oxygen deprivation, toxin exposure, or severe neurological injury — it can trigger excitotoxicity: sustained NMDA receptor activation drives an uncontrolled calcium influx that damages or kills neurons. This mechanism is central to the harm seen in stroke and traumatic brain injury.

Excitotoxicity is not a direct risk of NMDA-antagonist drugs, which block rather than activate the receptor. The concern is relevant in overdose contexts involving stimulants or other agents that can drive widespread neurological stress, and in understanding why certain brain injuries are so damaging.